Impaired Nicotinamide Adenine Dinucleotide Biosynthesis in the Kidney of Chronic Kidney Disease
Chronic kidney disease (CKD) is a global public health problem with high morbidity and mortality. Decreased nicotinamide adenine dinucleotide (NAD+) levels were found to be associated with aging, cancer, and neurodegenerative and metabolic disorders. However, the alteration of renal NAD+ levels and...
Main Authors: | Xinhui Liu, Denggui Luo, Shiying Huang, Siqi Liu, Bing Zhang, Fochang Wang, Jiandong Lu, Jianping Chen, Shunmin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.723690/full |
Similar Items
-
Nicotinamide phosphoribosyltransferase: Biology, role in cancer, and novel drug target
by: Antonio Lucena-Cacace, et al.
Published: (2018-01-01) -
Nicotinamide adenine dinucleotide+ metabolism biomarkers in malignant gliomas
by: Manuel P Jiménez-García, et al.
Published: (2016-01-01) -
Semisynthetic biosensors for mapping cellular concentrations of nicotinamide adenine dinucleotides
by: Olivier Sallin, et al.
Published: (2018-05-01) -
Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging
by: Raymond D. Palmer, et al.
Published: (2021-09-01) -
Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment
by: Lan Fan, et al.
Published: (2020-11-01)